In vitro T‐cell activation of monocyte‐derived macrophages by soluble messengers or cell‐to‐cell contact in bovine tuberculosis
- 1 June 2000
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 100 (2), 194-202
- https://doi.org/10.1046/j.1365-2567.2000.00027.x
Abstract
The macrophage plays a dual role in tuberculosis, promoting not only protection against mycobacteria, but also survival of the pathogen. Macrophages inhibit multiplication of mycobacteria but also act in concert with lymphocytes through presentation of antigens to T cells. Studies in animal and human infections have suggested a correlation of in vitro growth rates of mycobacteria with in vivo virulence, using uracil uptake to assess mycobacterial metabolism. This study found that blood-derived, non-activated bovine macrophages were capable of controlling Mycobacterium bovis bacillus Calmette-Gurin growth for up to 96 hr, but were permissive to intracellular growth of virulent M. bovis. The present investigation compared the in vitro modulation of these macrophage activities by cytokine-rich T-cell supernatants or cell-to-cell contact. On the one hand, treatment of cultured monocytes with mitogen-produced T-cell supernatants promoted morphological changes suggestive of an activation status, enhanced the antigen presentation capabilities of monocytes and up-regulated major histocompatibility complex class II expression. However, this activation was not associated with enhanced anti-M. bovis activity. On the other hand, incubation of infected monocytes with T-cell populations resulted in proportionally increased inhibition of M. bovis uracil uptake. This inhibition was also seen using cells from uninfected animals and indicated the necessity for cell-to-cell contact to promote antimycobacterial capability.Keywords
This publication has 54 references indexed in Scilit:
- Enhanced Capacity of a Widespread Strain ofMycobacterium tuberculosisto Grow in Human MacrophagesThe Journal of Infectious Diseases, 1999
- Cellular responses and Mycobacterium bovis BCG growth inhibition by bovine lymphocytesImmunology & Cell Biology, 1997
- Sequential activation of alveolar macrophages by IFN‐γ and LPS is required for enhanced growth inhibition of virulent Mycobacterium bovis but not M. bovis BCGImmunology & Cell Biology, 1997
- Bacterial metabolism, cytokine mRNA transcription and viability of bovine alveolar macrophages infected with Mycobacterium bovis BCG or virulent M bovisImmunology & Cell Biology, 1996
- Inability of normal human intestinal macrophages to form multinucleated giant cells in response to cytokines.Gut, 1995
- Immunity to intracellular microbial pathogensImmunology Today, 1995
- Differential release of tumor necrosis factor-α from murine peritoneal macrophages stimulated with virulent and avirulent species of mycobacteriaFEMS Immunology & Medical Microbiology, 1994
- Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells.The Journal of Experimental Medicine, 1988
- Pure interferon gamma enhances class II HLA antigens on human monocyte cell linesEuropean Journal of Immunology, 1984
- Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources.Journal of Histochemistry & Cytochemistry, 1977